Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6411 posts found.

bristol

Opdivo first PD-1 inhibitor given European approval for haematological cancer

November 25, 2016 Medical Communications, Sales and Marketing BMS, Bristol-Myers Squibb, EMA, PD1-Inhibitor, bristol myers-squibb

Bristol-Myers Squibb announced that it has received the first and only European approval for a PD1 inhibitor in the treatment …
News
celgene_1_02

NICE u-turns on Celgene’s drug for multiple myeloma

November 24, 2016 Medical Communications Celgene, NICE, imnovid

NICE has performed a U-turn on Celgene’s Imnovid (pomalidomide) based on new data and the offer of a price reduction. …
News
shutterstock_231613360

Non-small cell lung cancer market to hit $26bn by 2025

November 24, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GlobalData, non-small cell lung cancer

New research from GlobalData has indicated that the non-small cell lung cancer (NSCLC) market will rise in value by over …
News
navidea_cmyk

Navidea agrees deal worth $310 million with Cardinal

November 24, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cardinal, Navidea, Navidea biopharmaceutical

Navidea Biopharmaceuticals, a developer of immunodiagnostic agents and immunotherapeutics, has announced that they will enter into a definitive asset purchase …
News
juno

Patient deaths lead Juno Therapeutics to halt trial for second time

November 24, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing acute lymphoblastic leukaemia, clinical trial deaths, juno therapeutics

Juno Therapeutics has been forced to halt a trial investigating the efficacy of its lead experimental CAR-T cancer treatment JCAR015 …
News
lilly2_web

Lilly forced to abandon Alzheimer’s drug after failed trial

November 24, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, Alzheimer's disease, Eli Lilly

Eli Lilly announced that the results of its ‘Expedition 3’ trial for an experimental Alzheimer’s disease drug meant that they would …
News
allergan

Allergan acquires Chase Pharma in potential $1 billion deal

November 23, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Allergan announced that it has completed the acquisition of Chase Pharmaceutical Corporation in a deal worth a potential $1 billion. …
News
anthony_maddaluna

Anthony Maddaluna, executive vice president of Pfizer, to retire

November 23, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Anthony J. Maddaluna, who worked at Pfizer for more than 41 years, will retire from his positions of executive vice …
Appointment

Scientists identify an existing drug that could aid in therapy for brain swelling

November 23, 2016 Medical Communications, Research and Development University of Arkansas, concussion, head injury

A team of biomedical engineering researches, who performed their study at the University of Arkansas, have identified a drug that …
News
thomas_willemsen

Thomas Willemson promoted to China Area Head at GSK

November 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

GlaxoSmithKline appointed a new area head in Thomas Willemsen to take charge of its China drug business. He succeeds Herve …
Appointment

Mylan ducks call to testify in front of Senate

November 22, 2016 Manufacturing and Production, Medical Communications Department of Justice, Mylan, epipen

Mylan has avoided the call to testify in front of the Senate judiciary committee. The hearing will be convened under …
News
theresa_may

Theresa May promises £2 billion a year in funding for R&D

November 21, 2016 Manufacturing and Production, Medical Communications Conservative, Theresa May, brexit

The Conservative Party leader has announced a planned raise in funding for research and development for UK business to £2 …
News
pfizer_brussels

Pfizer sues Texas agency over leak of drug prices

November 21, 2016 Medical Communications, Sales and Marketing Drug pricing, Pfizer, US, texas

Pfizer has sued Texas’ Health and Human Services Commission, after it claimed the agency violated state and federal law by …
News
gsk_wall

GSK 18 months ahead of the game with three-drug inhaler

November 21, 2016 Medical Communications, Sales and Marketing GSK, Innoviva, chronic obstructive pulmonary disease

GlaxoSmithKline, alongside its partner Innoviva, have filed a regulatory submission with the FDA for its treatment for chronic obstructive pulmonary …
News
teva_copy

Teva’s drug to replace chemotherapy in acute leukaemia

November 21, 2016 Medical Communications, Sales and Marketing Teva, chemotherapy, first line, first-line, leukaemia

Teva Pharmaceutical announced that their drug Trisenox has been given approval from the European Commission to become the first line …
News
The Gateway to Local Adoption Series

Latest content

Sandoz opens biosimilar development centre in Slovenia

June 19, 2026

Codis announces three senior business development appointments

June 18, 2026

US laboratory approval supports launch of lung cancer blood test

June 17, 2026

Study to examine ways of improving diabetes care for younger adults

June 16, 2026

Phase 2 endometriosis trial reaches recruitment milestone

June 15, 2026